While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the sustainability of a trend isn't easy.Often, the direction of a stock's price movement reverses quickly after taking a position in it, making investors incur a short-term capital loss. So, it's important to ensure that there are enough factors -- such as sound fundamentals, positive earnings estimate revisions, ...

Core Viewpoint - BrightSpring Health Services, Inc. (BTSG) is currently positioned as a more attractive investment compared to Alignment Healthcare (ALHC) based on various valuation metrics and earnings outlook [1][3][7] Valuation Metrics - BTSG has a forward P/E ratio of 26.78, significantly lower than ALHC's forward P/E of 101.06, indicating that BTSG may be undervalued [5] - The PEG ratio for BTSG is 0.57, while ALHC's PEG ratio stands at 2.66, suggesting that BTSG offers better value relative to its expected earnings growth [5] - BTSG's P/B ratio is 4.14 compared to ALHC's P/B of 20.3, further highlighting the relative undervaluation of BTSG [6] Earnings Outlook - BTSG is experiencing an improving earnings outlook, which is a key factor in its strong Zacks Rank of 1 (Strong Buy), while ALHC holds a Zacks Rank of 3 (Hold) [3][7]

Company Overview - BrightSpring's headquarters is located in Louisville, and the meeting includes both in-person attendees and those joining via webcast [1] - The agenda includes a company overview by the CEO Jon Rousseau, followed by detailed reviews of pharmacy businesses [1] Pharmacy Business Review - The meeting will cover various segments of the pharmacy business, including specialty, infusion, and home and community pharmacy [1] - A Q&A session with pharmacy leaders will follow the pharmacy overview [1] Provider Business Review - After a break, the agenda will shift to provider businesses, starting with home health, hospice, rehab, and personal care [2] - A Q&A session with provider leaders is scheduled before lunch [2] Financial Discussion - Post-lunch, discussions will include insights from government relations and business development teams [2] - The financials of the company will be discussed, concluding with a wrap-up and Q&A session with Jon and other leaders [2] - The goal is to conclude the meeting by 2:00 p.m. Eastern [2]

BrightSpring Health Services, Inc. (BTSG) shares rallied 7.8% in the last trading session to close at $42.1. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 0.5% gain over the past four weeks.BrightSpring Health Services scored a strong price increase on investors’ optimism surrounding the company’s robust fourth quarter financial performance. It reported sales of $3.55 billion, up 29.3% year over year. The m ...

Market Overview - U.S. stock markets have experienced a downturn over the past three weeks due to geopolitical conflicts in the Middle East, particularly between the U.S.-Israel joint force and Iran, leading to increased crude oil and natural gas prices [1] - The Strait of Hormuz, a major oil supply line controlled by Iran, remains severely disturbed, raising concerns about global inflation [1] Stock Performance - A limited number of stocks have shown price strength during this downturn, with a focus on those that have recently been on a bull run [2] - Five stocks identified with strong price gains are Cardinal Infrastructure Group Inc. (CDNL), Escalade Inc. (ESCA), Century Aluminum Co. (CENX), BrightSpring Health Services Inc. (BTSG), and Constellium SE (CSTM) [2][7] Stock Analysis - Cardinal Infrastructure Group (CDNL) has seen a stock price increase of 34% in four weeks, with earnings estimates rising by 29.9% [7][8] - Escalade Inc. (ESCA) has experienced a price increase of 28.9% over the same period, with an expected earnings growth of 6.1% [10] - Century Aluminum Co. (CENX) has surged 15.6% in stock price, with an expected earnings growth rate exceeding 100% [13] - BrightSpring Health Services Inc. (BTSG) has advanced 9.5% in stock price, with an expected earnings growth rate of 61% [14] - Constellium SE (CSTM) has gained 7.5% in stock price, with an expected earnings growth rate of 6.8% [16] Investment Screening Criteria - Stocks were screened based on several parameters, including a percentage change in price over the last four weeks greater than zero and a percentage change over 12 weeks greater than 10% [4] - Additional criteria included a Zacks Rank of 1 (Strong Buy), an average broker rating of 1, a current price greater than $5, and a current price/52-week high-low range greater than 85% [5][6]

BrightSpring Health Services Inc. (NASDAQ:BTSG) is one of the 10 Stocks That Made Millionaires Today. BrightSpring rallied for a second day on Tuesday, jumping 7.81 percent to finish at $42.10 apiece, as investors welcomed the company’s reaffirmed growth outlook for this year. In a shareholders’ meeting on the same day, BrightSpring Health Services Inc. (NASDAQ:BTSG) maintained its total revenues growth guidance of 11.9 percent to 16.2 percent year-on-year, at $14.45 billion to $15 billion, with the phar ...

Core Viewpoint - Ten stocks showed strong performance on Tuesday, reflecting a broader market rally driven by positive company outlooks and analyst upgrades [1] Group 1: Stock Performances - Elanco Animal Health Inc. (NYSE:ELAN) increased by 7.61% to $25.18, supported by an optimistic outlook leveraging AI, aiming for 4-6% organic revenue growth and 8% adjusted EBITDA growth [4][5] - BrightSpring Health Services Inc. (NASDAQ:BTSG) rose by 7.81% to $42.10, maintaining a revenue growth guidance of 11.9% to 16.2%, with pharmacy revenues expected to grow by 10.1% to 14.5% [7][8] - Red Cat Holdings Inc. (NASDAQ:RCAT) bounced back by 9.20% to $16.97, anticipating a revenue surge of 1,800% in Q4 and 153% for the full year [11][12] - Western Digital Corp. (NASDAQ:WDC) climbed 9.64% to $313.81, reporting a 296% increase in diluted net income to $1.8 billion and a 25% revenue increase to $3.02 billion [14][15] - Planet Labs PBC (NYSE:PL) saw a 10.08% increase to $27.08, with full fiscal year revenue growth expected between $297 million and $301 million, reflecting a 21.5% to 23% year-on-year growth [17][18] Group 2: Financial Highlights - Elanco's revenues increased by 6% to $4.7 billion, despite a net loss of $232 million, with Q4 revenues up 12% to $1.144 billion [6] - BrightSpring's net income improved to $104.8 million from a net loss of $68.9 million, with revenues up 28.2% to $12.9 billion [9][10] - Red Cat's Q4 revenues are projected to be between $24 million and $26.5 million, a significant increase from $1.3 million in the same period last year [12] - Western Digital's revenues for the upcoming third quarter are targeted at $3.2 billion, with diluted earnings per share expected at $2.30 [16] - Planet Labs anticipates Q4 revenues of $76 million to $80 million, with a projected negative adjusted EBITDA of $5 million to $7 million [19]

BrightSpring Health Services (NasdaqGS:BTSG) 2026 Investor Day March 17, 2026 08:30 AM ET Company ParticipantsA.J. Rice - Managing Director of Equity ResearchBen Fernandez - Chief Commercial OfficerCharlie Wardrip - CIOChris Consalus - SVP of Corporate DevelopmentChris Urban - COODaryn Demeritt - SVP of Government RelationsDavid Deuchler - Managing DirectorElizabeth Robinson - President of Home HealthJared Haase - Equity Research AssociateJen Phipps - CFOJill Ford - Head of Equity Capital MarketsJon Roussea ...

BRIGHTSPRING INVESTOR DAY 29 79 145 38 154 188 141 198 63 213 133 18 200 200 200 143 143 143 70 184 218 Agenda March 17, 2026 1 Pharmacy Business Unit Overviews Specialty Pharmacy Infusion Pharmacy Home and Community Pharmacy The BrightSpring Platform Jon Rousseau, President and Chief Executive Officer Benito Fernandez, Chief Commercial Officer Robert Thomson, Chief Growth Officer Christopher Urban, RPh, Chief Operating Officer Rich Denness, President Scott Greenwell, PharmD, President Pharmacy Q&A Provider ...

Core Viewpoint - BrightSpring Health Services is focusing on operational efficiency, specialty pharmacy growth, and strategic acquisitions to drive long-term growth and improve outcomes through technology investments and centralized procurement [4][3][6]. Group 1: Technology and Efficiency Initiatives - The company is investing in leading systems to provide real-time data and improve outcomes, with a focus on building an internal AI team and collaborating with external vendors [1] - BrightSpring has launched seven to eight key multi-year efficiency initiatives for 2026, which include procurement, internal process improvements, systems, and automation [1][6] - A formalized lean culture has been established, executing over 100 projects across business units to enhance operational efficiency [2][6] Group 2: Growth Drivers - Long-term growth is driven by volume growth, operational efficiency, and selective M&A, with key drivers including economies of scale, product mix, and process discipline [3] - The specialty pharmacy segment is expected to see approximately 20 new brand launches, primarily in oncology, and is experiencing double-digit growth [5][8] - The company has been able to grow market share faster due to limited distribution drug launches and generic conversions [8] Group 3: Financial Performance and Strategy - Management has mitigated Inflation Reduction Act headwinds to approximately $15 million for 2026 through enhanced dispensing fees [5][11] - The company has reduced leverage to about 2.65x pro forma and aims to get under 2x while remaining selective on M&A due to elevated infusion multiples [5][16] - BrightSpring's institutional pharmacy operations are expanding, with skilled nursing facilities becoming a significant market for the business [12] Group 4: Provider Segment Focus - The company is concentrating on home health, hospice, and rehab services, with each performing well and opportunities for volume and margin improvement through strategic acquisitions [17] - BrightSpring is optimistic about regulatory reimbursement for home health, emphasizing the cost-saving benefits of home health services [18][19] - The company is integrating pharmacy services into home health and rehab, aiming to enhance care coordination for patients transitioning from skilled nursing facilities [22] Group 5: Cash Flow and Financial Outlook - The company did not provide guidance on free cash flow or operating cash flow for the year, citing various factors including the expected closing of the Community Living transaction [24] - Management expects to maintain the operating cash flow profile seen in 2025, with a discrete positive item tied to a tax savings initiative worth about $20 million [24]